Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-020 Gel for Seborrheic Keratoses and Non-Melanoma Skin Cancers
NCT06409195Phase 2Recruiting
- Sponsor
- DermBiont, Inc.
- Start
- Mar 2024
- Primary completion
- Nov 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SM-020 in seborrheic keratosis (SK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sponsored by DermBiont, Inc.. Started Mar 2024; status: recruiting.
02
Drugs
SM-020
03
Conditions
seborrheic keratosis (SK)basal cell carcinoma (BCC)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT06409195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06409195.